Pharma Pulse 7/19/24: Sentiments Surrounding At-Home Diagnostic Testing, Smaller Drugmakers Step Up Hunt for Acquisitions & more

Sentiments Surrounding At-Home Diagnostic Testing

In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s manager of biopharma, discusses findings of a new physician survey that the company conducted.

HHS Releases Part Two of Medicare Prescription Drug Payment Plan

Part two focuses on the requirement that Part D sponsors must make enrollees aware of upcoming benefits.

Smaller Drugmakers Step Up Hunt for Acquisitions

Midsize companies vie with larger players to purchase biotech companies.

GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound

GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a leader in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. GE HealthCare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease-of-use for the benefit of clinicians and patients.

Life Sciences Law at Epstein Becker Green on LinkedIn

A more thoughtful, bipartisan pandemic post-mortem: In an op-ed for Pharmaceutical Executive, attorney Richard Hughes IV writes that Congress and our nation’s public health officials should take the current moment to self-reflect and resolve challenges with public confidence in our public and scientific institutions.
#HealthPolicy #HealthCare #Pharmaceuticals

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs